RRSP Investors: 1 Safe Stock to Profit From the Cannabis Wave

Cannabis resale shakes up for medical marijuana suppliers like Canopy Growth (TSX:WEED)(NYSE:CGC).

| More on:

Alimentation Couche-Tard (TSX:ATD.B) has joined the cannabis industry officially as a retailer through recognizable brands such as Couche-Tard, Circle K, Ingo, and Topaz. On May 17, 2019, the retailer opened Ontario’s first marijuana retail store in partnership with Canopy Growth (TSX:WEED)(NYSE:CGC).

Alimentation had announced the partnership with Canopy Growth earlier this year after winning one of the first 25 marijuana retail licenses in Ontario. The agreement will position Alimentation to sell legal cannabis through the “Tweed” brand globally.

Alimentation generates more revenue than any other publicly traded Canadian company. For risk-conscious investors seeking to profit from marijuana legalization, Alimentation Couche-Tard is even safe enough for a registered retirement savings plan (RRSP). Alimentation shares climbed 27% this year and currently yield a dividend of 0.59%.

Alimentation opens first Tweed-branded store

Last month, residents in London, Ontario were the first to experience marijuana’s newfound legalization when Alimentation opened a licensed marijuana retail store under Canopy Growth’s trademark, Tweed. Following the store’s grand opening, the company reiterated positive, forward-looking statements on its multi-year agreement with Canopy Growth in its 2019 Annual Information Form.

The Alcohol and Gaming Commission of Ontario (AGCO) ran a random lottery to issue the first 25 medical cannabis licenses earlier this year. Alimentation won the lottery under the shell company 2674253 Ontario Inc and subsequently partnered with Canopy Growth to sell under the Tweed brand.

Although businesses were only required to submit a $75 application fee and a $50,000 letter of credit, the AGCO also mandated a $6,000 non-refundable fee. The lottery was only open to expressions of interest for five days; interested applicants faced a $25,000 fine if they were unable to begin retail operations by April 30, 2019.

Alimentation globally connects Canopy Growth

Alimentation is a global franchiser and independent operator of convenience stores. Since 1980, Alimentation has expanded its portfolio to six brands throughout Canada, the United States, Europe, Asia, Mexico, and Central America. The company earns over 40% of its revenue from tobacco products and stands ready to expand its merchandise to cannabis.

Investors can expect the Tweed partnership to galvanize growth in Alimentation’s profit margin and Canopy Growth’s geographic scope. Without a doubt, Canopy Growth will afford Alimentation stronger access to cannabis operating licenses and intellectual property rights. Meanwhile, Alimentation’s international network will expand Canopy Growth’s export capabilities heading into the 2020 fiscal year.

Cannabis exports explode

Under current federal laws, organizations may only export cannabis for medical and scientific purposes. Nevertheless, Canopy Growth reported in its March 2019 financial statement that it has already boosted its exports by 643.86% in one year from $3.7 million to $27.87 million. For the 2018 fiscal year, Canada Health reports national dried cannabis and cannabidiol exports of 537.5 kilograms and 756.3 litres, respectively.

Canopy Growth has expanded company access to operating licenses and intellectual property rights through strategic acquisitions, including a July 2018 acquisition of Spectrum Cannabis. Spectrum Cannabis began as a legal family medical marijuana business in Colombia following marijuana’s legalization in 2016.

Acquisition of this company added over $50,000 in operating license value to Canopy Growth and access to the South American market.

No doubt about it: Alimentation and Canopy Growth have formed the ideal partnership with strong first-mover advantage into the legal marijuana industry. As one of Canada’s strongest publicly traded companies, Alimentation provides conservative investors with safe dividends and reliable capital gains in the quickly growing legal marijuana market.

Should you invest $1,000 in Aurora Cannabis right now?

Before you buy stock in Aurora Cannabis, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Aurora Cannabis wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Debra Ray has no position in any of the stocks mentioned. Alimentation Couche-Tard is a recommendation of Stock Advisor Canada.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »